CIRCUMVENTION OF VINCRISTINE AND ADRIAMYCIN RESISTANCE INVITRO AND INVIVO BY CALCIUM INFLUX BLOCKERS
- 1 January 1983
- journal article
- research article
- Vol. 43 (6), 2905-2910
Abstract
Ca influx blockers, diltiazem, nicardipine, nifedipine, niludipine and nimodipine, which possess coronary vasodilatory activity, greatly enhanced the cytotoxicity of vincristine (VCR) in tumor cells and especially in VCR-resistant sublines of mouse P388 leukemia (P388/VCR) and human K562 myelogenous leukemia. The extent of enhancement was different among the drugs, and up to a 50- to 70-fold increase in VCR cytotoxicity occurred in P388/VCR cells with nontoxic or marginally toxic concentrations of diltiazem and nicardipine. A 50- to 100-fold enhancement occurred in VCR-resistant human K562 myelogenous leukemia cells with diltiazem, nicardipine, niludipine and nimodipine. VCR resistance of these cell lines was circumvented completely by these blockers. Ca influx blockers also enhanced the cytotoxicity of Adriamycin in P388 leukemia cells and especially in its Adriamycin-resistant subline. The extent of enhancement, however, was lower than that which occurred in VCR-resistant tumor lines with VCR. An .apprx. 10- to 30-fold increase in Adriamycin cytotoxicity occurred in P388 Adriamycin-resistant subline cells with diltiazem, nicardipine, niludipine, and nimodipine. Although VCR alone at 10-200 .mu.g/kg did not confer a significant therapeutic effect in P388/VCR-bearing mice, Ca influx blockers in doses of 30-125 mg/kg administered daily for 10 days with VCR enhanced the chemotherapeutic effect of VCR in P388/VCR-bearing mice. A maximum of .apprx. a 40 to 50% increase in life span occurred with diltiazem, nicardipine, niludipine and nimodipine. The Ca influx blockers also enhanced the therapeutic effect of Adriamycin in P388 Adriamycin-resistant subline-bearing mice, although the extent of enhancement was smaller than that observed with VCR in P388/VCR-bearing mice.This publication has 10 references indexed in Scilit:
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93)Biochemical Pharmacology, 1981
- OVERCOMING OF VINCRISTINE RESISTANCE IN P388 LEUKEMIA INVIVO AND INVITRO THROUGH ENHANCED CYTO-TOXICITY OF VINCRISTINE AND VINBLASTINE BY VERAPAMIL1981
- COMPARISON OF CYTOTOXIC EFFECT AND CELLULAR UPTAKE OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND ITS N4-ACYL DERIVATIVES, USING CULTURED KB CELLS1979
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.The Journal of Antibiotics, 1978
- Resistance and Cross-Resistance of Cultured Leukemia P388 Cells to Vincristine, Adriamycin, Adriamycin Analogs, and Actinomycin D2JNCI Journal of the National Cancer Institute, 1978
- MECHANISMS OF RESISTANCE TO DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS1978
- MECHANISM OF CROSS-RESISTANCE BETWEEN VINCRISTINE AND DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS1978
- INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA1978